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Background: A "hybrid" strategy selectively uses adenosine to measure FFR only in
lesions with an intermediate resting index (iFR or resting Pd/Pa). It trades off diag-
nostic accuracy against a reduced need for vasodilator administration. The ADVISE II
and SYNTAX II studies employ such an approach. However, its effect on treatment
decisions for coronary revascularization remains unclear compared to the evidence-
based strategy of FFR for all lesions. These tradeoffs are important when contem-
plating future outcomes trials testing a hybrid strategy.
Methods: The international, multicenter RESOLVE study applied the ofﬁcial
Volcano iFR software algorithm in a blinded core lab. Hybrid strategies for both iFR
(measure FFR only if iFR¼0.86-0.93) and resting Pd/Pa (measure FFR only if Pd/
Pa¼0.89-0.94) were applied. Based on DEFER, FAME and FAME 2, FFR>0.80
served as an unequivocal standard for no ischemia, FFR0.75 served as an
unequivocal standard for ischemia, and FFR 0.76-0.80 was intermediate.
Results: A total of 1,593 lesions were included. Both hybrid strategies required
adenosine for only 36% of lesions. Overall agreement with FFR in all lesions was
identical for both strategies: 89% for FFR0.80, rising to 96% when including gray-
zone FFR values 0.76-0.80. Total incorrect decisions (false positives plus false
negatives) slightly favored resting Pd/Pa over iFR: 178 vs 180 misclassiﬁed lesions for
FFR0.80; 62 vs 71 when including gray-zone FFR¼0.76-0.80. iFR always offered
more false positives but fewer false negatives.Table. Revascularization decisions in RESOLVE using hybrid strategies
Hybrid with
iFR
Hybrid with
resting Pd/Pa
Number of lesions
requiring adenosine
572 (36%) 570 (36%)
Number of lesions with low
rest index
503 (32%) 429 (27%)
Actual FFR0.75 (true
positives)
410 (82%) 374 (87%)
Actual FFR¼0.76-0.80
(intermediate)
61 (12%) 42 (10%)
Actual FFR>0.80 (false
positives)
32 (6%) 13 (3%)
FFR ¼ 0.81-0.85 27 lesions 10 lesions
FFR ¼ 0.86-0.89 5 lesions 3 lesions
Number of lesions with
high rest index
518 (33%) 594 (37%)
Actual FFR>0.80 (true
negatives)
431 (83%) 471 (79%)
Actual FFR¼0.76-0.80
(intermediate)
48 (10%) 74 (12%)
Actual FFR0.75 (false
negatives)
39 (8%) 49 (8%)
FFR  0.70 18 lesions 21 lesions
FFR ¼ 0.71-0.75 21 lesions 28 lesions
Coronary physiological parameters across the FFR/CFVR groups
FFR0.75
CFVR2.0
FFR0.75
CFVR<2.0
FFR<0.75
CFVR2.0
FFR<0.75
CFVR<2.0
(n¼100) (n¼22) (n¼26) (n¼9)
FFR 0.860.06c 0.820.05a,b,c 0.700.03a,b,c 0.630.10a
CFVR 2.80.7c 1.70.2a,b,c 2.70.5b,c 1.50.3a
HSR, mmHg/
cm/s
0.31 (0.19 -
0.48)c
0.52 (0.35 -
0.71)a,b,c
0.79 (0.66 -
0.89)a,b
0.78 (0.59 -
1.09)a
BMR, mmHg/
cm/s
6.29 (5.00 -
8.00)c
4.71 (3.78 -
6.29)a,b,c
6.52 (4.24 -
7.48)b,c
3.60 (2.24 -
4.23)a
HMR, mmHg/
cm/s
2.08 (1.65 -
2.63)c
2.29 (1.82 -
2.82)b,c
1.73 (1.41 -
2.04)a,b
1.52 (1.17 -
1.91)a
APV, cm/s
(Basal)
156c 2110a,b 167b,c 278a
APV, cm/s
(Hyperemia)
4113 3713 4218 4012
a p<0.05 compared with FFR0.75 CFVR2.0; b p<0.05 between the discordant groups;
c p<0.05 compared with FFR<0.75 CFVR<2.0
FFR: fractional ﬂow reserve; CFVR: coronary ﬂow velocity reserve; HSR: hyperemic stenosis
resistance index; BMR: basal microvascular resistance; HMR: hyperemic microvascular
resistanceConclusions: Future outcomes trials could compare a hybrid strategy to universal
FFR. RESOLVE suggests that resting Pd/Pa will perform at least as well as iFR for
this purpose. Given the z90-95% agreement with FFR, such trials could expect to
enroll only 2 clearly misclassiﬁed lesions (for FFR0.80, falling to 1 lesion when
including gray-zone FFR¼0.76-0.80) for every 20 screened.B192 JACC Vol 62/18/Suppl B j October 27–NovemTCT-633
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Background: The extremes of discordance between fractional ﬂow reserve(FFR) and
coronary ﬂow velocity reserve(CFVR) (e.g. normal FFR with abnormal CFVR versus
abnormal FFR with normal CFVR) are suggested to originate from diverging distri-
butions of epicardial and microvascular disease. In contrast, the origin of discordance
of CFVR with FFR within vessels with normal FFR and within vessel with abnormal
FFR has not been elucidated, which is typically of more pertinence in clinical practice.
We aimed to determine the physiological characteristics that delineate discordance of
CFVR with FFR in FFR-positive, as well as in FFR-negative stenoses.
Methods: 157 coronary stenoses were studied using intracoronary pressure and ﬂow
velocity measurements. We calculated FFR, CFVR, hyperemic stenosis resistance
index (HSR), as well as basal (BMR) and hyperemic (HMR) microvascular resistance
index. FFR0.75, and CFVR<2.0 was considered abnormal.
Results: When FFR<0.75, CFVR<2.0 resulted from a high baseline ﬂow velocity as
a consequence of a low BMR (Table, left panel). Similarly, when FFR0.75,
CFVR<2.0 occurred from a high baseline ﬂow velocity, corresponding to a low BMR
(Table, Right panel). The two groups in which FFR and CFVR were discordant, were
characterized by divergent distributions of epicardial and microvascular resistances.Conclusions: The magnitude of basal microvascular resistance is the major deter-
minant of discordance of CFVR with FFR within vessels with a normal FFR, as well
as within vessels with an abnormal FFR. This ﬁnding suggests that microvascular
abnormalities are the root cause of discordance of CFVR with FFR in patients with
a comparable degree of epicardial disease as identiﬁed by FFR, which may have
important implications for pressure-only stenosis evaluation.ber 1, 2013 j TCT Abstracts/POSTER/Physiologic Lesion Assessment
